Legal Representation
Attorney
Christopher N. Bolinger
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description |
|---|---|---|---|
| Jan 11, 2008 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Dec 12, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Mar 27, 2007 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Mar 27, 2007 | EEXT | I | TEAS EXTENSION RECEIVED |
| Mar 27, 2007 | EXT1 | S | EXTENSION 1 FILED |
| Mar 27, 2007 | EX1G | S | EXTENSION 1 GRANTED |
| Oct 3, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Jul 11, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jun 21, 2006 | NPUB | O | NOTICE OF PUBLICATION |
| May 25, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| May 19, 2006 | ALIE | A | ASSIGNED TO LIE |
| May 19, 2006 | ALIE | A | ASSIGNED TO LIE |
| May 11, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| May 11, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 21, 2006 | NWAP | I | NEW APPLICATION ENTERED IN TRAM |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations namely, cholesterol preparations, insomnia preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005